Binex Co Ltd
KOSDAQ:053030
Intrinsic Value
BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. [ Read More ]
The intrinsic value of one Binex Co Ltd stock under the Base Case scenario is 7 600.21 KRW. Compared to the current market price of 14 340 KRW, Binex Co Ltd is Overvalued by 47%.
Valuation Backtest
Binex Co Ltd
Run backtest to discover the historical profit from buying and selling Binex Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Balance Sheet Decomposition
Binex Co Ltd
Current Assets | 66.7B |
Cash & Short-Term Investments | 8.8B |
Receivables | 28.4B |
Other Current Assets | 29.6B |
Non-Current Assets | 182.3B |
Long-Term Investments | 27.7B |
PP&E | 128.7B |
Intangibles | 23B |
Other Non-Current Assets | 2.9B |
Current Liabilities | 72.1B |
Accounts Payable | 3.6B |
Accrued Liabilities | 5.6B |
Short-Term Debt | 31B |
Other Current Liabilities | 31.9B |
Non-Current Liabilities | 6B |
Long-Term Debt | 5.3B |
Other Non-Current Liabilities | 712.9m |
Earnings Waterfall
Binex Co Ltd
Revenue
|
136.3B
KRW
|
Cost of Revenue
|
-100.2B
KRW
|
Gross Profit
|
36.2B
KRW
|
Operating Expenses
|
-54B
KRW
|
Operating Income
|
-17.9B
KRW
|
Other Expenses
|
5.7B
KRW
|
Net Income
|
-12.2B
KRW
|
Free Cash Flow Analysis
Binex Co Ltd
KRW | |
Free Cash Flow | KRW |
Profitability Score
Profitability Due Diligence
Binex Co Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Binex Co Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Binex Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Binex Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Binex Co Ltd
According to Wall Street analysts, the average 1-year price target for Binex Co Ltd is 16 000 KRW .
Shareholder Return
Price
Binex Co Ltd
Average Annual Return | 34.26% |
Standard Deviation of Annual Returns | 131.23% |
Max Drawdown | -80% |
Market Capitalization | 443.5B KRW |
Shares Outstanding | 31 187 800 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Busan, Busan. The company went IPO on 2001-08-07. The Company’s products include digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as ointment, creams and others. The company also manufactures bio medicines and raw materials. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Binex Co Ltd stock under the Base Case scenario is 7 600.21 KRW.
Compared to the current market price of 14 340 KRW, Binex Co Ltd is Overvalued by 47%.